Ultragenyx Pharmaceutical (RARE) Revenue (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) revenue from Mar 31, 2013 to Mar 31, 2026. The TTM Ultragenyx Pharmaceutical (RARE) revenue is $670M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Ultragenyx Pharmaceutical (RARE) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +13.53% |
| 3 Years TTM | +20.40% |
| 5 Years TTM | +14.93% |
| All Time TTM | +117.43% |
Annual Revenue change of Ultragenyx Pharmaceutical (RARE)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $136M | -79.79% |
| 2025 | $673M | +20.18% |
| 2024 | $560M | +29.03% |
| 2023 | $434M | +19.45% |
| 2022 | $363M | +3.39% |
| 2021 | $351M | +29.66% |
| 2020 | $271M | +161.33% |
| 2019 | $104M | +101.38% |
| 2018 | $52M | +1873.18% |
| 2017 | $2.61M | +1907.69% |
| 2016 | $130K | N/A |
| 2015 | $0 | N/A |
| 2014 | $0 | N/A |
| 2013 | $0 | N/A |
| 2012 | $0 | N/A |
Comparison Ultragenyx Pharmaceutical (RARE) five years revenue CAGR with competitors
Ultragenyx Pharmaceutical (RARE) five years revenue CAGR is 14.93%.